April 2, 2025

A major Novosibirsk pharmaceutical manufacturer is planning to launch two new production facilities.

Pharma

The major Novosibirsk pharmaceutical manufacturer "Obnovlenie" (Renewal) plans to launch two new production facilities by 2027. This will ensure the localization of popular drugs such as diclofenac, ketorolac, ketoprofen, drotaverine, and pyridoxine. TASS reports this, citing the company.

As previously reported by RBC Novosibirsk, at the beginning of the year, the pharmaceutical company was granted a permit for the second phase of construction works to build Pharmaceutical Production Facility No. 7, an energy building, a warehouse, an administrative building, and garages. The construction site is located on Stantsionnaya Street in the Leninsky District of the city. The permit is valid until March 3, 2025.

The executive director of the pharmaceutical company Renewal ("PFC Obnovlenie"), Vladimir Grechkinn, told RBC Novosibirsk that the total cost of the project amounts to 3 billion rubles.

"Production Line No. 7 is being built for the production of solid dosage forms: capsules, tablets, and effervescent tablets. Importantly, the new site will provide the opportunity to create backup production capacities for future medications. The plant's production potential will increase by 100 million packages of drugs per year," Grechkinn explained.

Renewal ("Pharmaceutical Production Company Obnovlenie") is one of the largest Russian manufacturers of medicines, with its production and research complex located in Novosibirsk and the Suzun urban-type settlement. Since 1997, the company has been engaged in the development and production of pharmaceuticals.

 

Source: www.nsk.rbc.ru

Latest posts by email:
To subscribe to the newsletter, first Come in Either Register

Other news

Pharma

In today’s world, effective resource management is becoming an increasingly crucial aspect of successful business operations. This is especially true for industries where equipment plays a key role—such as pharmaceuticals, cosmetology, and the food industry.

02.10.2025
Pharma

A new administrative and production-warehouse complex of the pharmaceutical enterprise Farmstandart-UfaVITA has been commissioned in the center of Ufa. Investment exceeded 10 billion rubles, and new production lines are designed to produce 75 million medicine packages per year.

06.10.2026
Pharma

A Russian drugmaker, with the support of integrator IST-PAK, deployed an Italian SIEMPHARMA SRL counting-filling line for packaging tablets and capsules into plastic jars. The project was delivered despite a constrained shop floor and a fixed budget.

02.10.2026
Pharma

Farmasyntez Group commissioned a new pharmaceutical enterprise in Ussuriysk (Primorsky Krai). The plant with a design capacity of 12 million medicine packages a year was implemented under the import substitution program Pharma-2030; 90% of manufactured items are on the VED list.

01.10.2026
Pharma

Argumentum Pharma is completing the equipping of its new pharmaceutical plant in Moscow region's Dubna SEZ: high-tech automated filling and packaging lines have already been installed. Total investment in the project is estimated at 2.5 billion rubles, with commissioning planned before the end of 2026.

29.09.2026
Pharma

The Russian pharmaceutical manufacturer PFK "Renewal", operating under the Renewal brand, has commissioned a new production facility for the production of vital and essential medicines (VED) in the Novosibirsk region. The area of the complex exceeds 18.1 thousand square meters, and the design capacity reaches 100 million packages of finished products annually.

23.09.2026
Pharma

"VERTEX" is completing the commissioning of a blister-cardboard line with double-sided aluminum packaging, unique for its capacities. The new machine will become the tenth blister line of the enterprise and will allow to produce about 260 thousand packages by the end of 2026.

21.09.2026
Pharma

""""On Moscow Industry Day, Sergei Sobyanin opened a new production complex "Generium-Next" (GC "Farmstandart") at the Alabushevo site. The company will produce genetically engineered drugs for orphan and socially significant diseases for 8.5 billion rubles.

18.09.2026
Pharma

""PSK Pharma" company has completed a major project to modernize the production site of capsules with powder for inhalation at its own enterprise in the "Dubna" special economic zone. Investments exceeded 1 billion rubles, which made it possible to double the capacity of the line — from 80 to 160 thousand capsules per hour — and purchase new analytical and tablet equipment.

17.09.2026
Pharma

PJSC "Biosynthesis", one of the largest pharmaceutical enterprises in the Penza region, is preparing to launch a reconstructed production site for tablet dosage forms. The volume of investments in the project is 350 million rubles, and the implementation will increase the production of drugs, including those included in the list of VED.

16.09.2026
Pharma

Pharmaceutical manufacturer "Nizhpharm" announced the launch of a new line of packaging and packaging of soft dosage forms. The volume of investments in the project amounted to 158 million rubles, the maximum speed of the equipment reaches 270 packages per minute, which will increase production by 50%.

15.09.2026
Pharma

Gerresheimer, a German company specializing in glass, specialty glass, and plastic packaging for the pharmaceutical, cosmetic, and food industries, announced the commissioning of a new plant in Zhenjiang, China.

27.07.2026